Skip to content
Medical Health Aged Care, Research Development

Global Dementia Research Must Reflect Global Diversity

Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney 2 mins read

A major international research effort led by UNSW’s Centre for Healthy Brain Ageing (CHeBA) is reshaping our understanding of dementia by addressing a longstanding gap in global health equity.

A new paper published in a special issue of Neuroscience on ‘Global Diversity and Disparity in Mental Health and Brain Health’ highlights how the Cohort Studies of Memory in an International Consortium (COSMIC) is helping to make dementia research more inclusive, equitable, and globally relevant.

Led by CHeBA Research Fellow Dr Darren Lipnicki, this paper summarises the research that has been published by the COSMIC consortium.  It shows that dementia risk factors do not affect all populations equally. COSMIC’s global approach has uncovered key differences in how cardiovascular, lifestyle, and social factors relate to dementia across populations - differences that could help shape more effective, tailored prevention strategies.

“If we want to reduce the future burden of dementia globally, we need to understand how risk factors play out in diverse settings,” said Professor Perminder Sachdev, leader of the COSMIC consortium and Co-Director of CHeBA.

“What works for high-income countries may not apply in low- and middle-income regions. We need solutions that fit local realities.”

The need for this work is pressing. More than 55 million people worldwide are living with dementia, with 10 million new cases every year. As the global population ages, this number is projected to triple to 153 million by 2050, with the most rapid growth occurring in low- and middle-income countries. Despite this, these populations remain severely underrepresented in existing research.

Since its inception in 2012, COSMIC has brought together data from over 60 cohort studies across 38 countries - spanning Asia, Africa, Europe, the Americas, and Australia - with more than 200,000 participants. This allows researchers to explore how age, genetics, education, environment, and gender intersect with dementia risk across ethnic and geographic lines.

Dr Lipnicki says the latest findings demonstrate some key issues:

  • Stronger effects of cardiovascular risk factors (like diabetes and high cholesterol) on cognitive decline among Asian populations compared to White populations;
  • Social factors, such as family interaction and community support, more strongly protecting against dementia in Asian countries;
  • Differences in the impact of education, parity, and genetics on dementia risk between regional and ethnic groups.

COSMIC is also addressing critical gaps by developing risk models and diagnostic tools suited for use in low-resource settings, building international capacity, especially training researchers in low- and middle-income countries (LMICs), supporting global data access through Dementias Platform Australia (DPAU), a secure platform also led by CHeBA that enables researchers worldwide to collaborate on COSMIC data.

As the global burden of dementia rises, this inclusive research approach has never been more urgent.

COSMIC invites new cohort studies - particularly from underrepresented or LMIC populations - to join the collaboration and ensure that the future of dementia research and prevention is truly global.

 

About COSMIC:
COSMIC is an international consortium of cohort studies working to understand cognitive ageing and dementia by analysing harmonised data from diverse populations worldwide. It is supported by an RO1 grant from the National Institute of Health/ National Institute of Aging, USA.

COSMIC: Cohort Studies of Memory in an International Consortium | Centre for Healthy Brain Ageing (CHeBA)

 


Contact details:

Heidi Douglass

[email protected]

0435 579 202

Media

More from this category

  • Government Federal, Medical Health Aged Care
  • 11/12/2025
  • 14:21
Hepatitis Australia and ASHM

Australia’s leading hepatitis experts reaffirm support for birth-dose hepatitis B vaccination

Australia’s foremost hepatitis researchers and clinicians have released a joint expert statement confirming that Australia’s recommendation remains unchanged: all medically stable newborns who meet the weight threshold should receive their first dose of the hepatitis B vaccine within 24 hours of birth. The statement follows international attention after a U.S. advisory panel recommended reversing its long-standing advice that infants receive the hepatitis B vaccine at birth. Hepatitis Australia CEO Lucy Clynes said parents and healthcare professionals should remain confident in Australia’s long-standing, evidence-based approach. “Australia’s advice has not changed. The hepatitis B birth-dose vaccination is safe, effective and one of…

  • Medical Health Aged Care
  • 11/12/2025
  • 10:10
Royal Australian College of GPs

Commonsense health check decision a win for patients and GPs

The Royal Australian College of General Practitioners (RACGP) has welcomed a Medical Board of Australia (MBA) decision to not introduce mandatory health checks for GPs aged 70 and over. Rather than adding to the already burdensome regulatory environment for GPs, the RACGP has consistently argued that the focus should instead be on supporting doctors’ wellbeing. The MBA had previously proposed introducing general health checks for late-career doctors aged 70 and older to support early detection of concerns but has instead committed to a profession-led approach. RACGP President Dr Michael Wright said the MBA had made the right call. “We are…

  • Contains:
  • Medical Health Aged Care
  • 11/12/2025
  • 07:42
Palliative Care Australia

Australia can relieve hospital ‘bed block’ with palliative care investment

Palliative Care Australia (PCA), the peak body for palliative care in Australia, has injectednew ideasinto the debate on how to relieve “bed block” in…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.